Developing therapies that improve and create lives.

Cell engineering is curing diseases from cancer to heart disease. We believe novel advances in the field can cure diseases of the female reproductive system – for good.

We are here to make a change.

From PCOS to infertility, most diseases of the female reproductive system have few treatment options, and those that do exist cause complications and don’t cure the underlying disease.

At the core of our work is cell engineering. We are developing a modern and robust platform of therapies to study and treat these conditions.

US Headquarters:
New York, NY
European Headquarters:
Madrid, Spain

We bring together scientists, innovators, and experts passionate about modernizing and improving women's health

Dina Radenkovic
Co-founder & CEO
Christian Kramme
VP of Cellular Engineering
Milos Fulton
VP of Business Operations
David McCulloh
VP of Embryology
Agustina Imfeld
Counsel
Dina Radenkovic
Dina Radenkovic
CEO and Director
Martin Varsavsky
Martin Varsavsky
Chairman
Maryanna Saenko
Maryanna Saenko
Director
Dylan Morris
Dylan Morris
Director

Scientific Advisory Board

Professor George Church
Professor George Church
Professor Kristin Baldwin
Professor Kristin Baldwin
Professor Philip Jordan
Professor Philip Jordan
Dr Sara Vaughn
Dr Sara Vaughn
Professor Mary Herbert
Professor Mary Herbert
Professor Pranam Chatterjee
Professor Pranam Chatterjee

Bioethics Committee

Alta Charo
Alta Charo
Leslie Schrock
Leslie Schrock
Andrew Mclaughlin
Andrew Mclaughlin

Join us

If you’re interested in joining our mission-driven team and would like to contribute to our work, please take a look at our open positions or get in touch.

Careers

Our investors help us modernize and improve reproductive technology

Future
Insight Partners
Bold
Arcadia
Plumalley
Lux
TAV
Salt
FJ Labs
Overwater Ventures
Anne Wojcicki
Anne Wojcicki
23 and Me
Robert Nelsen
Robert Nelsen
Arch Ventures
Jack Abraham
Jack Abraham
Atomic
Dan Rose
Dan Rose
Coatue Ventures